Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study-Reference-Cited by-同舟云学术

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study

Published:2014-01-23 Issue:7 Volume:53 Page:939-944
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Hofland Kenneth F.,Hansen Steinbjørn,Sorensen Morten,Engelholm Silke,Schultz Henrik P.,Muhic Aida,Grunnet Kirsten,Ask Anders,Costa Junia C.,Kristiansen Charlotte,Thomsen Carsten,Poulsen Hans Skovgaard,Lassen Ulrik

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.879607

Reference25 articles.

1. The biology of VEGF and its receptors

2. A Review of VEGF/VEGFR-Targeted Therapeutics for Recurrent Glioblastoma

3. A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

2. State of the neoadjuvant therapy for glioblastoma multiforme—Where do we stand?;Neuro-Oncology Advances;2024-01-01

3. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia;Frontiers in Oncology;2023-01-17

4. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

5. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline;Journal of Clinical Oncology;2022-02-01